Pair 1:
Robert Balshaw
University of Manitoba
Winnipeg, Manitoba
Robert Balshaw’s interests include innovative trials design, causal inference in observational studies, methods for biomarker discovery, refinement and validation. He is becoming very curious about the Bayesian approach to scientific thinking.
Robert Balshaw
University of Manitoba
Winnipeg, Manitoba
Lauren Kelly
University of Manitoba
Winnipeg, Manitoba
Dr. Kelly is an Assistant Professor in the department of pharmacology and therapeutics at the University of Manitoba, director of clinical trials at the Children’s Hospital Research Institute of Manitoba and Principal Investigator for the clinical pharmacology lab. Dr. Kelly is a certified clinical research professional who leads several clinical trials on cannabinoid therapeutics as the scientific director for the Canadian Collaborative for Childhood Cannabinoid Therapeutics (C4T). She also provides methods expertise and training in clinical trials for researchers across Manitoba in her role as a Clinical Trialist at the George and Fay Yee Centre for Healthcare Innovation. Dr. Kelly is a consultant with the Conect4Children pan-European clinical trials network and KidsCan Trials within the Maternal Infant Child Youth Research Network.
Lauren Kelly
University of Manitoba
Winnipeg, Manitoba
Robert Balshaw
University of Manitoba
Winnipeg, Manitoba
Robert Balshaw’s interests include innovative trials design, causal inference in observational studies, methods for biomarker discovery, refinement and validation. He is becoming very curious about the Bayesian approach to scientific thinking.
Robert Balshaw
University of Manitoba
Winnipeg, Manitoba
Robert Balshaw’s interests include innovative trials design, causal inference in observational studies, methods for biomarker discovery, refinement and validation. He is becoming very curious about the Bayesian approach to scientific thinking.
Lauren Kelly
University of Manitoba
Winnipeg, Manitoba
Dr. Kelly is an Assistant Professor in the department of pharmacology and therapeutics at the University of Manitoba, director of clinical trials at the Children’s Hospital Research Institute of Manitoba and Principal Investigator for the clinical pharmacology lab. Dr. Kelly is a certified clinical research professional who leads several clinical trials on cannabinoid therapeutics as the scientific director for the Canadian Collaborative for Childhood Cannabinoid Therapeutics (C4T). She also provides methods expertise and training in clinical trials for researchers across Manitoba in her role as a Clinical Trialist at the George and Fay Yee Centre for Healthcare Innovation. Dr. Kelly is a consultant with the Conect4Children pan-European clinical trials network and KidsCan Trials within the Maternal Infant Child Youth Research Network.
Lauren Kelly
University of Manitoba
Winnipeg, Manitoba
Dr. Kelly is an Assistant Professor in the department of pharmacology and therapeutics at the University of Manitoba, director of clinical trials at the Children’s Hospital Research Institute of Manitoba and Principal Investigator for the clinical pharmacology lab. Dr. Kelly is a certified clinical research professional who leads several clinical trials on cannabinoid therapeutics as the scientific director for the Canadian Collaborative for Childhood Cannabinoid Therapeutics (C4T). She also provides methods expertise and training in clinical trials for researchers across Manitoba in her role as a Clinical Trialist at the George and Fay Yee Centre for Healthcare Innovation. Dr. Kelly is a consultant with the Conect4Children pan-European clinical trials network and KidsCan Trials within the Maternal Infant Child Youth Research Network.